nVerses Capital LLC acquired a new stake in CVS Health Co. (NYSE:CVS – Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,600 shares of the pharmacy operator’s stock, valued at approximately $101,000.
A number of other large investors also recently modified their holdings of CVS. Pzena Investment Management LLC increased its position in shares of CVS Health by 132.9% in the 2nd quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock valued at $764,023,000 after purchasing an additional 7,382,931 shares during the last quarter. Capital International Investors increased its position in shares of CVS Health by 12.5% in the 1st quarter. Capital International Investors now owns 37,917,923 shares of the pharmacy operator’s stock valued at $3,024,334,000 after purchasing an additional 4,226,225 shares during the last quarter. Capital World Investors increased its position in shares of CVS Health by 8.0% in the 1st quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock valued at $3,491,643,000 after purchasing an additional 3,232,172 shares during the last quarter. State of Michigan Retirement System increased its position in shares of CVS Health by 402.5% in the 2nd quarter. State of Michigan Retirement System now owns 2,005,677 shares of the pharmacy operator’s stock valued at $118,455,000 after purchasing an additional 1,606,500 shares during the last quarter. Finally, Swedbank AB purchased a new stake in shares of CVS Health in the 1st quarter valued at approximately $110,816,000. 80.66% of the stock is owned by hedge funds and other institutional investors.
CVS Health Stock Down 5.2 %
CVS stock opened at $60.34 on Monday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company has a fifty day moving average of $59.80 and a 200-day moving average of $60.43. The stock has a market capitalization of $75.75 billion, a PE ratio of 10.60, a price-to-earnings-growth ratio of 0.93 and a beta of 0.54.
CVS Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.41%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is 46.75%.
Analyst Ratings Changes
A number of research analysts recently commented on CVS shares. Barclays raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $63.00 to $82.00 in a research report on Thursday, October 10th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Truist Financial increased their target price on shares of CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research report on Friday, October 11th. Finally, TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and increased their target price for the company from $59.00 to $85.00 in a research report on Friday, October 4th. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.26.
Read Our Latest Stock Analysis on CVS
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
- Five stocks we like better than CVS Health
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is Spotify Stock Poised to Soar? Options Traders Think So
- What Are Dividend Contenders? Investing in Dividend Contenders
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Stock Market Sectors: What Are They and How Many Are There?
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.